63 related articles for article (PubMed ID: 12934389)
1. [Distribution and metabodynamics of hepatocyte targeting vector molecules in vivo].
Ouyang CH; Lu FG; Yang DY
Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):26-8. PubMed ID: 12934389
[TBL] [Abstract][Full Text] [Related]
2. Targeting specificity and pharmacokinetics of asialoorosomucoid, a specific ligand for asialglycoprotein receptor on hepatocyte.
Yang DY; Ouyang CH; Lu FG; Liu XW; Huang LQ
J Dig Dis; 2007 May; 8(2):89-95. PubMed ID: 17532821
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeled constructs for evaluation of the asialoglycoprotein receptor status and hepatic functional reserves.
Abe M; Lai J; Kortylewicz ZP; Nagata H; Fox IJ; Enke CA; Baranowska-Kortylewicz J
Bioconjug Chem; 2003; 14(5):997-1006. PubMed ID: 13129404
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hepatocarcinoma by systemic delivery of Apoptin gene via the hepatic asialoglycoprotein receptor.
Peng DJ; Sun J; Wang YZ; Tian J; Zhang YH; Noteborn MH; Qu S
Cancer Gene Ther; 2007 Jan; 14(1):66-73. PubMed ID: 16874360
[TBL] [Abstract][Full Text] [Related]
5. Feasibility on systemic delivery of asialoorosomucoid complex to hepatic origin cells mediated by asialoglycoprotein receptor.
Jun S; Xia J; Wang Y; Wang Y; Yiqiang Z; Shen Q
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):234-5, 239. PubMed ID: 16201257
[TBL] [Abstract][Full Text] [Related]
6. [Molecular conformation and expression efficiency in the hepatocyte targeting gene drug].
Lu FG; Liu XW; Ou Yang CH
Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):9-12. PubMed ID: 12575220
[TBL] [Abstract][Full Text] [Related]
7. Study on the variables affecting toxicity of hybrid toxins. The effect of different target cell receptor distribution and toxin binding chain.
Chang TM; Chang CH
Biochim Biophys Acta; 1989 Oct; 1013(3):239-46. PubMed ID: 2804085
[TBL] [Abstract][Full Text] [Related]
8. ZT glue immobilizes iodinated oil in vivo.
Xuguang Z; Longbao X; Rui L; Renhua W
Eur J Radiol; 2006 Nov; 60(2):287-92. PubMed ID: 16860506
[TBL] [Abstract][Full Text] [Related]
9. [Study on the hepatocytic cell targetability of liposomes].
Hou XP; Wang L; Wang XT; Li S
Yao Xue Xue Bao; 2003 Feb; 38(2):143-6. PubMed ID: 12778752
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of hepatotropic targeting properties of allogenic and xenogenic erythrocyte ghosts in normal and liver-injured rats.
Gressner OA; Lahme B; Koch M; Gressner AM
Liver Int; 2008 Feb; 28(2):220-32. PubMed ID: 18069973
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the molecular conformation of a hepatocyte-targeting gene drug in order to improve its expression efficiency in vitro.
Liu XW; Lu FG; Wu XP; Ouyang CH; Yang DY; You Y; Lian GH
Chin J Dig Dis; 2005; 6(1):37-42. PubMed ID: 15667557
[TBL] [Abstract][Full Text] [Related]
12. Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers.
Yuan SH; Ge WH; Huo J; Wang XH
Fundam Clin Pharmacol; 2009 Apr; 23(2):189-96. PubMed ID: 19298236
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and uptake of liposomes in vivo.
Kamps JA; Scherphof GL
Methods Enzymol; 2004; 387():257-66. PubMed ID: 15172169
[No Abstract] [Full Text] [Related]
14. Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs.
Zhang C; Qu G; Sun Y; Yang T; Yao Z; Shen W; Shen Z; Ding Q; Zhou H; Ping Q
Eur J Pharm Sci; 2008 Apr; 33(4-5):415-23. PubMed ID: 18337069
[TBL] [Abstract][Full Text] [Related]
15. Characterization of novel kidney-specific delivery system using an alkylglucoside vector.
Shirota K; Kato Y; Suzuki K; Sugiyama Y
J Pharmacol Exp Ther; 2001 Nov; 299(2):459-67. PubMed ID: 11602655
[TBL] [Abstract][Full Text] [Related]
16. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
[TBL] [Abstract][Full Text] [Related]
17. The use of PVP as a polymeric carrier to improve the plasma half-life of drugs.
Kaneda Y; Tsutsumi Y; Yoshioka Y; Kamada H; Yamamoto Y; Kodaira H; Tsunoda S; Okamoto T; Mukai Y; Shibata H; Nakagawa S; Mayumi T
Biomaterials; 2004 Jul; 25(16):3259-66. PubMed ID: 14980420
[TBL] [Abstract][Full Text] [Related]
18. Auxiliary liver organ formation by implantation of spleen-encapsulated hepatocytes.
Nishio R; Nakayama M; Ikekita M; Watanabe Y
Tissue Eng; 2006 Sep; 12(9):2565-72. PubMed ID: 16995789
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin clearance is reduced at the late stage of polymicrobial sepsis.
Wu R; Zhou M; Cui X; Simms HH; Wang P
Int J Mol Med; 2003 Nov; 12(5):777-81. PubMed ID: 14533009
[TBL] [Abstract][Full Text] [Related]
20. [Targeting glycyrrhetinic acid to hepatic stellate cells in treating rat liver fibrosis].
Zhang QS; Luk JM; Zhang J; Tian GY
Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):664-7. PubMed ID: 16174454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
